NYSE · Healthcare

Xtant Medical Holdings, Inc. (XTNT)

As-reported financials and recent SEC filings for Xtant Medical Holdings, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$133.9M

Net income

$5.0M

Net margin

3.7%

Diluted EPS

$0.03

ROE

9.8%

P/E (TTM)

—

Market cap

—

Debt / equity

0.2×

Income statement (as reported)

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$133.9M	$117.3M	$91.3M	$58.0M	$55.3M
Gross profit	$84.3M	$68.2M	$55.5M	$32.1M	$32.5M
Operating income	$7.3M	$-12.1M	$-10.2M	$-6.8M	$-3.9M
Net income	$5.0M	$-16.4M	$660,000	$-8.5M	$-4.8M
Diluted EPS	$0.03	$-0.12	$0.01	$-0.09	$-0.06

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

ARS2026-06-23

DEFA14A2026-06-23

DEF 14A2026-06-23

SD2026-05-29

S-8 POS2026-05-13

S-8 POS2026-05-13

S-8 POS2026-05-13

S-8 POS2026-05-13

Largest Healthcare peers

UNH

UNITEDHEALTH GROUP INC

All Healthcare companies →

Go deeper on XTNT

Search Xtant Medical Holdings, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.